Advertisement

High-Content Screening in Forward (Phenotypic Screening with Organisms) and Reverse (Structural Screening by NMR) Chemical Genetics

  • Benoît DÉPREZ
Chapter

Abstract

High-content screening (HCS) aims not only to isolate molecules that are active towards a biological target but also to obtain the maximum amount of information during the screening about the effect of the molecule on this target. Here the notion of ‘biological target’ covers both molecularly defined biomolecules and complex biological systems. When the targets are identified molecularly, the effects of the targeted molecules can be studied on the isolated target in vitro (structural screening in parallel) or on the target in its cellular context, in vivo. These are procedures in reverse chemical genetics (chapter 8). It is also possible to search for molecules active on metabolic or signalling pathways without any molecular characterisation of the target. Phenotypic screening with cells or whole organisms are approaches in forward chemical genetics (chapter 8).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BIRD D.M., OPPERMAN C.H., JONES S.J., BAILLIE D.L. (1999) The Caenorhabditis elegans genome: a guide in the post genomics age. Annu. Rev. Phytopathol. 37: 247-265CrossRefGoogle Scholar
  2. HAJDUK P.J., GERFIN T., BOEHLEN J.M., HABERLI M., MAREK D., FESIK S.W. (1999) Highthroughput nuclear magnetic resonance-based screening. J. Med. Chem. 42: 2315-2317CrossRefGoogle Scholar
  3. WIDMER H., JAHNKE, W. (2004) Protein NMR in biomedical research. Cell Mol. Life Sci. 61: 580-599Google Scholar
  4. SMET C., DUCKERT J.-F., WIERUSZESKI J.-M., LANDRIEU I., BUEE L., LIPPENS G., DEPREZ B. (2005) Control of Protein-Protein Interactions: Structure-Based Discovery of Low Molecular Weight Inhibitors of the Interactions between Pin1 WW Domain and Phosphopeptides. J. Med. Chem. 4 8(15): 4815-4823CrossRefGoogle Scholar
  5. KALETTA K., HENGARTNER M.O. (2006) Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5: 347-398CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Benoît DÉPREZ
    • 1
  1. 1.Pasteur Institute of LilleUniversity of LilleLilleFrance

Personalised recommendations